Table 3 Clinical and pathological characteristics according to breast carcinoma type
Variables | Luminal-A | Her-2 | TN | |
|---|---|---|---|---|
N = 10 | N = 10 | N = 10 | p-value | |
Age (years) | 66.5 (46.8-85.3) | 54.0 (49.8-63.0) | 68.5 (50.8-76.0) | 0.477 |
Clinicopathological parameters | ||||
Nottingham combined histologic grade | <0.001* | |||
Grade I (%) | 5 (50) | 0 (0) | 1 (10) | |
Grade II (%) | 4 (40) | 0 (0) | 0 (0) | |
Grade III (%) | 1 (10) | 10 (100) | 9 (90) | |
TNM Stage | 0.779 | |||
Stage I-II (%) | 9 (90) | 8 (80) | 8 (80) | |
Stage III-IV (%) | 1 (10) | 1 (10) | 2 (20) | |
Unknown (%) | 0 (10) | 1 (10) | 0 (10) | |
Tumor size (cm) | 2.25 (1.88-3.62) | 2.75 (1.73-4.12) | 3.25 (2.57-4.25) | 0.349 |
Lymph node affected (%) | 4 (40) | 3 (30) | 3 (30) | 0.861 |
Vascular invasion (%) | 1 (10) | 2 (20) | 1 (10) | 0.749 |
Tumor necrosis (%) | 1 (10) | 6 (60) | 5 (50) | 0.054 |
Ki-67 (%) | 5.00 (4.50-7.75) | 30.00 (12.50-42.50)a | 65.00 (21.25-82.50) b | 0.001* |
Ki-67 over 20 (%) | 0 (0) | 7 (70) | 8 (80) | 0.001* |
Other conditions | ||||
Dyslipidemia (%) | 2 (20) | 1 (10) | 8 (80) | 0.003* |
Menopause (%) | 5 (50) | 6 (60) | 4 (40) | 0.537 |